213 related articles for article (PubMed ID: 17675791)
1. Aspirin for primary prevention of cardiovascular disease in Japan.
Morimoto T; Matsui K
Intern Med; 2007; 46(15):1281. PubMed ID: 17675791
[No Abstract] [Full Text] [Related]
2. Should patients stop taking aspirin for primary prevention?
Depta JP; Bhatt DL
Cleve Clin J Med; 2015 Feb; 82(2):91-6. PubMed ID: 25897597
[No Abstract] [Full Text] [Related]
3. Aspirin for the prevention of cardiovascular disease: recommendation statement.
Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
[No Abstract] [Full Text] [Related]
4. Bleeding risk with aspirin must be balanced against benefit.
Harv Heart Lett; 2012 Aug; 22(12):8. PubMed ID: 23025025
[No Abstract] [Full Text] [Related]
5. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
6. Aspirin for Primary Prevention Reduces Cardiovascular Events, Increases Bleeding Risk.
Rosenberg K
Am J Nurs; 2019 May; 119(5):66. PubMed ID: 31033560
[No Abstract] [Full Text] [Related]
7. [Does combination therapy of aspirin plus antiplatelet therapy increase the risk of upper gastrointestinal hemorrhage?].
Kim JH
Korean J Gastroenterol; 2011 Apr; 57(4):205-6. PubMed ID: 21519172
[No Abstract] [Full Text] [Related]
8. Is low-dose aspirin safe for you? If you take daily aspirin, make sure you know why and understand the small but real bleeding risk.
Harv Mens Health Watch; 2012 Oct; 17(3):3. PubMed ID: 23175863
[No Abstract] [Full Text] [Related]
9. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
Rodondi N; Bauer DC
Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
[No Abstract] [Full Text] [Related]
10. A health impact assessment of increased aspirin use in Wales.
Williams WR
Public Health; 2006 May; 120(5):480; author reply 481. PubMed ID: 16549078
[No Abstract] [Full Text] [Related]
11. Aspirin for the prevention of cardiovascular disease.
Lin KW
Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
[No Abstract] [Full Text] [Related]
12. Aspirin and gastrointestinal toxicity.
Törüner M
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
McKeogh DF
N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12803214
[No Abstract] [Full Text] [Related]
14. Should aspirin be used for the primary prevention of cardiovascular disease in the general population?
Huang QY; Yang RQ
Med Princ Pract; 2015; 24(2):198. PubMed ID: 25377538
[No Abstract] [Full Text] [Related]
15. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
Mutter J; Grandy R; Hulkower S; Stigleman S
J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
[TBL] [Abstract][Full Text] [Related]
16. Appropriate aspirin use for primary prevention of cardiovascular disease.
Miser WF
Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
[No Abstract] [Full Text] [Related]
17. [Gastrointestinal bleeding during low dose acetylsalicylic acid. Is Godamed-100 TAH an alternative to conventional ASS preparations?].
Maywald U; Schindler C
Dtsch Med Wochenschr; 2005 Apr; 130(16):1026-7. PubMed ID: 15830316
[No Abstract] [Full Text] [Related]
18. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
[No Abstract] [Full Text] [Related]
19. Antiplatelet therapy in the treatment of Takayasu arteritis.
Ueno M
Circ J; 2010 Jun; 74(6):1079-80. PubMed ID: 20472963
[No Abstract] [Full Text] [Related]
20. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
Wolk MJ; Jacobs AK
N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15843675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
